Cervical Osteoarthritis Management

Introduction to PRP Therapy

The American College of Rheumatology/Arthritis Foundation strongly recommends against PRP treatment for osteoarthritis due to inconsistent evidence of benefit and concerns about standardization, requiring further high-quality trials to determine efficacy 1, 2, 3
The lack of standardization in PRP preparation methods leads to significant variability in biological properties and potential efficacy, with PRP products varying widely in platelet concentration, presence of leukocytes and red blood cells, preparation methods, and activation protocols 4, 5

First-line care for osteoarthritis should focus on exercise therapy, patient education, and weight loss (if appropriate), as these interventions have been consistently recommended across high-quality clinical practice guidelines for reducing pain and improving function, supported by the American College of Rheumatology and the VA/DoD Clinical Practice Guideline 1, 2, 3, 5

Current clinical practice guidelines recommend against the use of PRP for cervical osteoarthritis due to insufficient evidence supporting its efficacy, with most studies focusing on knee osteoarthritis and having moderate to high risk of bias, poor patient stratification, and lack of standardized outcome measures 1, 2, 3, 6
If considering PRP despite limited evidence, proper characterization of the PRP product and biorepository banking of samples for quality control are essential, and standardized outcome measures should be used to assess response, with any benefits potentially being temporary 5
Alternative treatments, such as disease-modifying anti-rheumatic drugs (DMARDs) and intra-articular corticosteroid injection, have established efficacy for rheumatoid arthritis and persistent local knee inflammation, respectively 2, 3, 6
Viscosupplementation may be considered for knee OA only when other interventions fail, but PRP should not be routinely offered due to strong recommendations against its use in current guidelines, supported by the American College of Rheumatology/Arthritis Foundation and the VA/DoD Clinical Practice Guideline 2, 3, 6

No serious adverse effects have been consistently reported in studies, and PRP is generally considered safe as it uses the patient's own blood products, although studies evaluating PRP for knee OA have shown inconsistent outcomes, leading to concerns about standardization and efficacy 6, 2, 3
The American College of Rheumatology/Arthritis Foundation and the VA/DoD Clinical Practice Guideline have expressed concerns about the use of PRP for hip or knee OA due to inconsistent study results and lack of proven efficacy for improving morbidity, mortality, or quality of life 2, 3, 6